Literature DB >> 2845801

Central catecholaminergic system stimulates secretion of CRH at different sites.

A Szafarczyk1, V Guillaume, B Conte-Devolx, G Alonso, F Malaval, N Pares-Herbuté, C Oliver, I Assenmacher.   

Abstract

To explore a possible differential role of distinct catecholamine (CA) innervation sites in corticotropin-releasing hormone (CRH) secretion, especially under stress conditions, we compared the effects in adult female rats of selective CA denervation of either the whole hypothalamus, by a discrete pharmacological lesion of the ventral noradrenergic ascending bundle [VNAB; 3 micrograms of 6-hydroxydopamine (6-OHDA) in 0.2 microliter of vehicle, bilaterally] or of the paraventricular nuclei (PVN) alone (1 microgram of 6-OHDA in 0.2 microliter of vehicle, bilaterally). Although both procedures induced a similar dramatic fall in norepinephrine and epinephrine concentrations (-55 to -65%) measured by high-performance liquid chromatography in PVN punches, the VNAB lesion, unlike PVN denervation, depleted the median eminence (ME) of both amines (-80%). Concomitantly, the VNAB lesion led to a 97% reduction of the immunoreactive (ir) CRH-41 concentration in the hypophysial portal vessels, associated with a 64% fall in plasma adrenocorticotropic hormone (ACTH), and, in another group, with an 80% inhibition of ether stress-induced ACTH surge. The deletion of CA innervation of the PVN alone reduced irCRH-41 levels in the portal vessels by only 57% and plasma ACTH by 35%. This lesion did not significantly impair stress-induced ACTH release. These results suggest that the CA innervation of the hypothalamus exerts a stimulatory control on CRH-41-secreting neurons not only directly at the perikaryal level but also at other hypothalamic sites of VNAB innervation including peripheral contacts between the terminals of CA and CRH nerves in the external ME.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845801     DOI: 10.1152/ajpendo.1988.255.4.E463

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Maternal attenuation of hypothalamic paraventricular nucleus norepinephrine switches avoidance learning to preference learning in preweanling rat pups.

Authors:  Kiseko Shionoya; Stephanie Moriceau; Peter Bradstock; Regina M Sullivan
Journal:  Horm Behav       Date:  2007-06-29       Impact factor: 3.587

Review 2.  Measuring the activity of brain adrenergic receptors in man.

Authors:  S al-Damluji
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

3.  The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors.

Authors:  S Gaillet; J Lachuer; F Malaval; I Assenmacher; A Szafarczyk
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

4.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.

Authors:  J P Liu; I J Clarke; J W Funder; D Engler
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 5.  Neuroendocrine and behavioral mechanisms mediating the relationship between anger expression and cardiovascular risk: assessment considerations and improvements.

Authors:  Mustafa al'Absi; Stephan Bongard
Journal:  J Behav Med       Date:  2006-11-10

6.  Systemic administration of leptin decreases plasma corticosterone levels: role of hypothalamic norepinephrine.

Authors:  Kimberly A Clark; Andew C Shin; Madhu P Sirivelu; Sheba M J Mohankumar; P S Mohankumar
Journal:  Brain Res       Date:  2007-12-14       Impact factor: 3.252

7.  Activation of the stress axis and neurochemical alterations in specific brain areas by concentrated ambient particle exposure with concomitant allergic airway disease.

Authors:  Madhu P Sirivelu; Sheba M J MohanKumar; James G Wagner; Jack R Harkema; Puliyur S MohanKumar
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

8.  PVN pathways controlling energy homeostasis.

Authors:  Jennifer W Hill
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  Neuroendocrine effects of perfluorooctane sulfonate in rats.

Authors:  Maureen E Austin; Badrinarayanan S Kasturi; Matthew Barber; Kurunthachalam Kannan; Puliyur S MohanKumar; Sheba M J MohanKumar
Journal:  Environ Health Perspect       Date:  2003-09       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.